Jung, G., Brandl, M., Eisner, W., Fraunberger, P., Reifenberger, G., Schlegel, U., Wiestler, O. and Wilmanns, W. (2001) Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situ Tcell activation and therapeutic efficacy. International Journal of Cancer, 91, 225-230. doi:10.1002/1097-0215(200002)9999:9999<::AID-IJC1038>3.3.CO;2-7

has been cited by the following article:

• TITLE: Construction, expression and binding specificity of bispecific CD3 × VEGFR-2 and CD3 × NCAM antibodies in the single chain and diabody format

  AUTHORS: Anke Kopacek, Thomas Böldicke, Sarah Lergenmüller, Frank Berthold, Markus Jensen, Peter P. Müller, Ludger Grosse-Hovest

  KEYWORDS: Recombinant Antibody; Single Chain Diabody; Bispecific Antibody; Protein Expression

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.4 No.5, May 30, 2013

  ABSTRACT: Bispecific antibodies are recombinant proteins with novel immunological properties and therapeutic potential. Recombinant protein quality and activity of several bispecific antibodies comprising different variable domain combinations with respect to the parental monospecific single chain fragments (scFv) were evaluated after expression in bacteria or mammalian cells. The parental scFv proteins humanized anti-NCAM scFv, murine anti-VEGFR-2 scFv, murine and humanized anti-CD3 scFv, respectively, could successfully be expressed in E. coli, whereas the murine anti-NCAM scFv version could not be reliably detected. Bispecific CD3 × VEGFR-2 and CD3 × NCAM anti-bodies were expressed in the bispecific single chain and the single chain diabody format. However, the diabody derived from the murine anti-NCAM scFv could not efficiently be expressed in E. coli or in mammalian cells. Significant binding of the CD3 × NCAM single chain diabody comprising the humanized version of anti-CD3 and humanized version of anti-NCAM was efficient to both antigens. Nevertheless, binding of the bispecific single chain version to the NCAM antigen was inefficient in comparison to CD3 binding. In conclusion, the data could indicate that the result of scFv expression in bacteria may be predictive for the chances of success for functional expression of more complex bispecific derivatives.